Vidac Pharma Holding Plc (HAM:T9G)
Germany · Delayed Price · Currency is EUR 0.5680
+0.0180 (3.27%)
At close: May 7, 2026
Vidac Pharma Holding Market Cap
Vidac Pharma Holding has a market cap or net worth of €21.94 million as of September 4, 2026.
Market Cap
21.94M
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
€0.57
ChartMarket Cap Chart
Since December 15, 2025, Vidac Pharma Holding's market cap has decreased from 26.85M to 21.94M, a decrease of -18.27%. That is a compound annual growth rate of -24.50%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 3, 2026 | 21.94M | -20.71% |
| Dec 30, 2025 | 27.67M | 3.08% |
| Dec 15, 2025 | 26.85M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biotest GmbH & Co. KGaA | 1.31B |
| Novogenia AG | 76.20M |
| 2invest AG | 43.64M |
| Biomark Diagnostics | 30.24M |
| Vidac Pharma Holding | 20.29M |
| co.don AG | 360.77K |
| Paion AG | 328.15K |
| bioXXmed AG | 312.65K |